BioLife Solutions Operating Margin 2010-2025 | BLFS
Current and historical operating margin for BioLife Solutions (BLFS) over the last 10 years. The current operating profit margin for BioLife Solutions as of March 31, 2025 is -2.12%.
| BioLife Solutions Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.09B | $-0.01B | -5.68% |
| 2024-12-31 | $0.08B | $-0.01B | -8.54% |
| 2024-09-30 | $0.06B | $0.01B | 12.90% |
| 2024-06-30 | $0.06B | $-0.01B | -9.09% |
| 2024-03-31 | $0.06B | $-0.01B | -23.21% |
| 2023-12-31 | $0.08B | $-0.02B | -31.58% |
| 2023-09-30 | $0.05B | $0.05B | 100.00% |
| 2023-06-30 | $0.07B | $0.05B | 79.10% |
| 2023-03-31 | $0.08B | $-0.01B | -16.46% |
| 2022-12-31 | $0.08B | $-0.01B | -9.09% |
| 2022-09-30 | $0.16B | $-0.12B | -74.19% |
| 2022-06-30 | $0.15B | $-0.11B | -77.03% |
| 2022-03-31 | $0.14B | $-0.04B | -30.43% |
| 2021-12-31 | $0.12B | $-0.04B | -29.41% |
| 2021-09-30 | $0.10B | $-0.02B | -22.68% |
| 2021-06-30 | $0.07B | $-0.01B | -16.22% |
| 2021-03-31 | $0.05B | $-0.01B | -13.21% |
| 2020-12-31 | $0.05B | $-0.01B | -12.50% |
| 2020-09-30 | $0.04B | $0.00B | -4.88% |
| 2020-06-30 | $0.04B | $0.00B | -5.41% |
| 2020-03-31 | $0.03B | $0.00B | -2.94% |
| 2019-12-31 | $0.03B | 0 | 0.00% |
| 2019-09-30 | $0.03B | $0.00B | 8.00% |
| 2019-06-30 | $0.02B | $0.00B | 17.39% |
| 2019-03-31 | $0.02B | $0.00B | 19.05% |
| 2018-12-31 | $0.02B | $0.00B | 15.79% |
| 2018-09-30 | $0.02B | $0.00B | 11.76% |
| 2018-06-30 | $0.02B | $0.00B | 6.67% |
| 2018-03-31 | $0.01B | 0 | 0.00% |
| 2017-12-31 | $0.01B | 0 | 0.00% |
| 2017-09-30 | $0.01B | $0.00B | -10.00% |
| 2017-06-30 | $0.01B | $0.00B | -22.22% |
| 2017-03-31 | $0.01B | $0.00B | -50.00% |
| 2016-12-31 | $0.01B | $-0.01B | -62.50% |
| 2016-09-30 | $0.01B | $-0.01B | -62.50% |
| 2016-06-30 | $0.01B | $-0.01B | -62.50% |
| 2016-03-31 | $0.01B | $0.00B | -57.14% |
| 2015-12-31 | $0.01B | $0.00B | -57.14% |
| 2015-09-30 | $0.01B | $0.00B | -57.14% |
| 2015-06-30 | $0.01B | $0.00B | -66.67% |
| 2015-03-31 | $0.01B | $0.00B | -66.67% |
| 2014-12-31 | $0.01B | $0.00B | -50.00% |
| 2014-09-30 | $0.01B | $0.00B | -33.33% |
| 2014-06-30 | $0.01B | $0.00B | -14.29% |
| 2014-03-31 | $0.01B | 0 | 0.00% |
| 2013-12-31 | $0.01B | 0 | 0.00% |
| 2013-09-30 | $0.01B | 0 | 0.00% |
| 2013-06-30 | $0.01B | 0 | 0.00% |
| 2013-03-31 | $0.01B | 0 | 0.00% |
| 2012-12-31 | $0.01B | 0 | 0.00% |
| 2012-09-30 | $0.01B | 0 | 0.00% |
| 2012-06-30 | $0.00B | 0 | 0.00% |
| 2012-03-31 | $0.00B | 0 | 0.00% |
| 2011-12-31 | $0.00B | 0 | 0.00% |
| 2011-09-30 | $0.00B | 0 | 0.00% |
| 2011-06-30 | $0.00B | 0 | 0.00% |
| 2011-03-31 | $0.00B | 0 | 0.00% |
| 2010-12-31 | $0.00B | 0 | 0.00% |
| 2010-09-30 | $0.00B | 0 | 0.00% |
| 2010-06-30 | $0.00B | 0 | 0.00% |
| 2010-03-31 | $0.00B | $0.00B | -100.00% |
| 2009-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.017B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.550B | 25.75 |
| Boston Scientific (BSX) | United States | $155.224B | 37.07 |
| Stryker (SYK) | United States | $149.901B | 30.56 |
| EssilorLuxottica (ESLOY) | France | $137.930B | 0.00 |
| Medtronic (MDT) | Ireland | $115.737B | 16.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.985B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.363B | 24.18 |
| ResMed (RMD) | United States | $39.874B | 28.48 |
| Agilent Technologies (A) | United States | $32.613B | 21.26 |
| GE HealthCare Technologies (GEHC) | United States | $32.562B | 15.31 |
| Koninklijke Philips (PHG) | Netherlands | $25.229B | 16.69 |
| Terumo (TRUMY) | Japan | $25.051B | 32.54 |
| Insulet (PODD) | United States | $20.296B | 79.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.133B | 11.65 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.385B | 0.00 |
| Baxter (BAX) | United States | $11.167B | 8.63 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.584B | 24.05 |
| Lantheus Holdings (LNTH) | United States | $4.925B | 12.42 |
| Perrigo (PRGO) | Ireland | $3.667B | 9.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.654B | 16.33 |
| Haemonetics (HAE) | United States | $3.557B | 16.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.202B | 21.97 |
| ICU Medical (ICUI) | United States | $3.160B | 23.31 |
| LeMaitre Vascular (LMAT) | United States | $1.836B | 41.03 |
| AtriCure (ATRC) | United States | $1.745B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.557B | 10.71 |
| Acuren (TIC) | United States | $1.347B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.251B | 28.14 |
| AdaptHealth (AHCO) | United States | $1.210B | 12.29 |
| Phibro Animal Health (PAHC) | United States | $1.074B | 13.73 |
| Neogen (NEOG) | United States | $1.010B | 16.03 |
| Curaleaf Holdings (CURLF) | Canada | $0.905B | 0.00 |
| InMode (INMD) | Israel | $0.863B | 7.99 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Valneva SE (VALN) | France | $0.625B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.596B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.585B | 0.00 |
| Evolus (EOLS) | United States | $0.575B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.44 |
| ZimVie (ZIMV) | United States | $0.523B | 20.42 |
| CeriBell (CBLL) | United States | $0.520B | 0.00 |
| Surmodics (SRDX) | United States | $0.513B | 0.00 |
| SNDL (SNDL) | Canada | $0.452B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.374B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.330B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.300B | 11.03 |
| Quanterix (QTRX) | United States | $0.297B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
| Cerus (CERS) | United States | $0.245B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.241B | 20.30 |
| Omeros (OMER) | United States | $0.239B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.238B | 0.00 |
| Biote (BTMD) | United States | $0.223B | 6.26 |
| Brainsway (BWAY) | Israel | $0.221B | 58.40 |
| Sanara MedTech (SMTI) | United States | $0.215B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.211B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.205B | 0.00 |
| Exagen (XGN) | United States | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.87 |
| Organigram Global (OGI) | Canada | $0.180B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.176B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.160B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.124B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.117B | 14.45 |
| Jushi Holdings (JUSHF) | United States | $0.111B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| MacroGenics (MGNX) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.49 |
| Quipt Home Medical (QIPT) | United States | $0.096B | 0.00 |
| Safety Shot (SHOT) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Apyx Medical (APYX) | United States | $0.072B | 0.00 |
| Veru (VERU) | United States | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 50.71 |
| United-Guardian (UG) | United States | $0.036B | 12.38 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |